Theranica said today that it won FDA de novo clearance for its Nerivio Migra remote electrical neuromodulation system intended for the acute treatment of migraines. The approval came based off a prospective, randomized, double-blind, placebo-controlled, multi-center pivotal study of 252 patients, the Israel-based company said. Data from the study was published in Headache: The Journal of […]
Omron joins $35m Theranica Series B
Theranica said today that Omron‘s (TYO:6645) venture arm joined a $35 million Series B financing round to support its remote neuromodulation technology. Israel-based Theranica is developing the Nerivio Migra neurostimulation patch intended to treat migraine headache, which is currently under FDA review. Funding in the round, which was initially announced in March, was led by […]
Theranica raises $35m Series B for neuromod migraine patch
Theranica Bio-Electronics said yesterday that it raised a $35 million Series B round for the Nerivio Migra neurostim patch it’s developing to treat migraine headache. Netanya, Israel-based Theranica said VC shop aMoon led the round, joined by all of its existing backers, Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa. The company raised an […]
Theranica raises seed round for Nerivio Migra wearable migraine device
Newly-formed med device company Theranica Bio-Electronics said today it closed a seed financing round led by Dr. Shimon Eckhouse and joined by a group of angel investors. The company did not release the amount raised in the round. Israel-based Theranica is developing the Nerivio Migra, a disposable neuromodulation patch designed to treat migraine headaches. “Theranica […]
MassDevice Network
@MassDevice
LinkedIn
YouTube